AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy

被引：0
|
作者：
HQ Nguyen
F Okuku
F Ssewankambo
AS Magaret
C Johnston
A Wald
A Kambugu
L Corey
J Orem
C Casper
机构：
[1] University of Washington,Department of Epidemiology
[2] University of Washington,Department of Laboratory Medicine
[3] University of Washington,Deparment of Medicine
[4] Program in Biostatistics,undefined
[5] Fred Hutchinson Cancer Research Center,undefined
[6] Program in Vaccine and Infectious Disease Institute,undefined
[7] Fred Hutchinson Cancer Research Center,undefined
[8] Uganda Cancer Institute,undefined
[9] Infectious Disease Institute,undefined
来源：
Infectious Agents and Cancer | / 4卷 / Suppl 2期
关键词：
Lamivudine; Efavirenz; Nevirapine; Stavudine; Karnofsky Score;
D O I：
10.1186/1750-9378-4-S2-O5
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [31] Therapy of AIDS-associated Kaposi's sarcoma: targeting pathogenetic mechanisms
    Krown, SE
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2003, 17 (03) : 763 - +
  • [32] Clinical presentations and standard therapy of AIDS-associated Kaposi's sarcoma
    Von Roenn, JH
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2003, 17 (03) : 747 - +
  • [33] Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy
    Palmieri, C.
    Dhillon, T.
    Thirlwell, C.
    Newsom-Davis, T.
    Young, A-M
    Nelson, M.
    Gazzard, B. G.
    Bower, M.
    HIV MEDICINE, 2006, 7 (05) : 291 - 293
  • [34] Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma?
    Dalla Pria, Alessia
    Hayward, Katy
    Bower, Mark
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (02) : 203 - 209
  • [35] Cidofovir added to highly active antiretroviral therapy in AIDS-associated progressive multifocal leukoencephalopathy
    Herrero-Romero, M
    Cordero, E
    López-Cortés, LF
    de Alarcón, A
    Pachón, J
    AIDS, 2001, 15 (06) : 809 - 809
  • [36] AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy
    Deutsch, R
    Ellis, RJ
    McCutchan, JA
    Marcotte, TD
    Letendre, S
    Grant, I
    AIDS, 2001, 15 (14) : 1898 - 1899
  • [37] Successful treatment with paclitaxel of advanced AIDS-associated Kaposi's sarcoma
    Kobayashi, M
    Takaori-Kondo, A
    Shindo, K
    Mizutani, C
    Ishikawa, T
    Uchiyama, T
    INTERNAL MEDICINE, 2002, 41 (12) : 1209 - 1212
  • [38] Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection
    Loke, W. C.
    Spittle, M. F.
    Mitchell, S.
    Kulasegaram, R.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2006, 17 (08) : 565 - 566
  • [39] Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings
    Epeldegui, Marta
    Chang, Di
    Lee, Jeannette
    Magpantay, Larry I.
    Borok, Margaret
    Bukuru, Aggrey
    Busakhala, Naftali
    Godfrey, Catherine
    Hosseinipour, Mina C.
    Kang, Minhee
    Kanyama, Cecilia
    Langat, Deborah
    Mngqibisa, Rosie
    Mwelase, Noluthando
    Nyirenda, Mulinda
    Samaneka, Wadzanai
    Hoagland, Brenda
    Campbell, Thomas B.
    Martinez-Maza, Otoniel
    Krown, Susan E.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2023, 94 (02) : 165 - 173
  • [40] A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa
    Mosam, Anisa
    Shaik, Fahmida
    Uldrick, Thomas S.
    Esterhuizen, Tonya
    Friedland, Gerald H.
    Scadden, David T.
    Aboobaker, Jamila
    Coovadia, Hoosen M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 60 (02) : 150 - 157
12345